Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wales
-
Cardiff, Wales, United Kingdom, CF14 4XN
- School of Medicine, Cardiff University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- People with Parkinson's Disease
- Hoehn and Yahr stages 1-3 of the disease
Exclusion Criteria:
- Patients with dementia or significant comorbidity
- those who fail the safety screening to go into an MRI scanner
- those who cannot travel to the University
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Neurofeedback and Physical Exercise
This group will undergo neurofeedback intervention in the fMRI scanner in weeks 1,5 and 12.
They will also undergo physical exercise training on WiiFit device once a week after the first month till the end of the study at 12 weeks.
|
|
|
Active Comparator: Physical Exercise
This group will undergo Physical Exercise intervention on the WiiFit device 3 times a week in the first month and once a week after the first month till the end of the study at 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS)
Time Frame: Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS) in 12 weeks
|
Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS) in 12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39)
Time Frame: Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) at 4 weeks
|
Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) at 4 weeks
|
|
Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39)
Time Frame: Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) in 12 weeks
|
Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) in 12 weeks
|
|
Change from baseline in the 'Actigraph'
Time Frame: Change from baseline in the 'Actigraph' at 12 weeks
|
Change from baseline in the 'Actigraph' at 12 weeks
|
|
Change from baseline in the 'GaitRite'
Time Frame: Change from baseline in the 'GaitRite' at 12 weeks
|
Change from baseline in the 'GaitRite' at 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: David Linden, MD, PhD, Cardiff University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SPON997-11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.